{
    "clinical_study": {
        "@rank": "23456", 
        "acronym": "FH Care", 
        "arm_group": {
            "arm_group_label": "Family Hypercholesterolemia in cardiology"
        }, 
        "brief_summary": {
            "textblock": "The Family Hypercholesterolemia remains poorly diagnosed disease with an outlet sometimes\n      suboptimal care. However, the Family Hypercholesterolemia exposes patients concerned at\n      increased cardiovascular risk.\n\n      The frequency of familial hypercholesterolemia in cardiologic is little studied and remains\n      unknown, and there is little data on the profile of patients, diagnostic methods and\n      management.\n\n      Main objectives:\n\n        -  Establish a monitoring patients with hypercholesterolemia Family cardiology in France\n\n        -  Characterize the Family hypercholesterolemia in cardiology, including assessing the\n           frequency of the most severe forms, which are at higher cardiovascular risk."
        }, 
        "brief_title": "French Observatory of Familial Hypercholesterolemia in Cardiology", 
        "completion_date": {
            "#text": "April 2023", 
            "@type": "Anticipated"
        }, 
        "condition": "Familial Hypercholesterolemia", 
        "condition_browse": {
            "mesh_term": [
                "Hypercholesterolemia", 
                "Hyperlipoproteinemia Type II"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  coronary patients\n\n          -  who agreed to participate\n\n          -  high LDL-c levels: * LDL-c> = 1.9g / l without lipid lowering treatment according to\n             the diagnostic score of Family Hypercholesterolemia these coronary patients with LDL>\n             1.9g / l may possibly or probably be achieved Hypercholesterolemia Family.\n\n        or\n\n        * LDL-c> = 1.6g / l in lipid-lowering treatment, the reduction of LDL-c average expected\n        under standard lipid-lowering therapy (statin alone) being 30-40% of these patients had\n        therefore pretreatment levels greater than 2 g / l or greater than 2.5 g / l and may\n        possibly or probably be achieved Family Hypercholesterolemia after the diagnostic score.\n\n        Exclusion Criteria:\n\n          -  Expressed refusal to participate in the observatory\n\n          -  Age \u2264 18"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "The study is proposed to cardiology services hospitals. Aged 18 or more, seen in\n        cardiology (USIC, Hospitalization, Consultation), who agreed to participate in the\n        observatory, and coronary patients who have LDL-c levels"
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02013713", 
            "org_study_id": "12 449"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cardiology", 
            "Family Hypercholesterolemia"
        ], 
        "lastchanged_date": "December 11, 2013", 
        "location": {
            "contact": {
                "last_name": "Albert Hag\u00e8ge"
            }, 
            "contact_backup": {
                "email": "edrouet@cardio-sfc.org", 
                "last_name": "Genevi\u00e8ve Mulak", 
                "phone": "+33 (0)1 44 90 70 28"
            }, 
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75015"
                }, 
                "name": "European Hospital Georges Pompidou"
            }, 
            "investigator": {
                "last_name": "Albert Hag\u00e8ge", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "French Observatory of Familial Hypercholesterolemia in Cardiology", 
        "overall_contact": {
            "email": "edrouet@sfcardio.fr", 
            "last_name": "Albert HAGEGE", 
            "phone": "33(1) 43 22 33 33"
        }, 
        "overall_contact_backup": {
            "email": "edrouet@sfcardio.fr", 
            "last_name": "Genevi\u00e8ve MULAK", 
            "phone": "33(1) 44 90 70 35"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France : CNIL (National Commission on Onformatics and Freedoms) - Authorization N\u00b0912411", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2022", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Number of Family Hypercholesterolemia among patients with LDL-C> 1.9g / l without hypoglycemic treatment or> 1.6g / l in lipid-lowering therapy", 
            "measure": "Frequency of the Family Hypercholesterolemia in cardiology", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "reference": {
            "PMID": "15177124", 
            "citation": "Civeira F; International Panel on Management of Familial Hypercholesterolemia. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis. 2004 Mar;173(1):55-68. Review."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02013713"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "French Cardiology Society", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "French Cardiology Society", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}